HSPA1A and benign prostatic hyperplasia: Third, since the expression of HSPA1A could not be completely depleted by KNK437 In vivo, a targeted inhibitor of HSPs, the Hspa1a−/− mouse model, was required to further determine its role in the development of BPH.